Fentanyl

Generic Name
Fentanyl
Brand Names
Abstral, Actiq, Duragesic, Effentora, Fentora, Instanyl, Lazanda, Sublimaze, Subsys, PecFent
Drug Type
Small Molecule
Chemical Formula
C22H28N2O
CAS Number
437-38-7
Unique Ingredient Identifier
UF599785JZ
Background

Fentanyl, a potent opioid agonist, was developed in the 1950s to fill a need for strong and rapid analgesia. Because of these characteristics, fentanyl is commonly used to treat chronic cancer pain or in anesthesia. Fentanyl is related to other opioids like morphine and oxycodone.
...

Indication

Fentanyl intravenous or intramuscular injections are indicated for short term analgesia during induction, maintenance, and recovery from general or regional anesthesia. These injections are also used with a neuroleptic for premedication, induction, and as an adjunct to maintenance of anesthesia. Finally, fentanyl intravenous or intramuscular injections are u...

Associated Conditions
Cancer Related Pain (Breakthrough Pain), Severe, Chronic Pain
Associated Therapies
Anesthetic premedication therapy, Anesthetics Agent, General Anesthesia, Induction of anesthesia therapy, Maintenance of anesthesia therapy, Regional Anesthesia therapy
Clinical Trials
Related News

Pharmaco-Economic Study Of Ultiva In Intensive Care Unit(ICU)Subjects

Phase 4
Completed
Conditions
Sedation
First Posted Date
2005-09-12
Last Posted Date
2008-10-16
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
224
Registration Number
NCT00158873
Locations
🇳🇱

GSK Investigational Site, Zwolle, Netherlands

Sensory Examination and Pharmacological Modulation of Oral Hyperexcitability in Patients With Atypical Odontalgia and Matched Healthy Controls

Phase 4
Completed
Conditions
Odontalgia
First Posted Date
2005-06-21
Last Posted Date
2006-06-20
Lead Sponsor
University of Aarhus
Target Recruit Count
20
Registration Number
NCT00115102
Locations
🇩🇰

Danish Pain Research Center, Aarhus, Denmark

Characterization of Pain Processing Mechanisms in Irritable Bowel Syndrome

Phase 2
Completed
Conditions
Irritable Bowel Syndrome
First Posted Date
2005-04-18
Last Posted Date
2009-01-21
Lead Sponsor
US Department of Veterans Affairs
Registration Number
NCT00108446
Locations
🇺🇸

Malcom Randall VAMC, Gainesville, Florida, United States

Herb-Opioid Interactions

Phase 4
Completed
Conditions
Pain
First Posted Date
2001-11-16
Last Posted Date
2007-02-08
Lead Sponsor
National Center for Complementary and Integrative Health (NCCIH)
Target Recruit Count
54
Registration Number
NCT00027014
Locations
🇺🇸

Fred Hutchinson Cancer Research Center, Seattle, Washington, United States

Randomized Study of Propofol Versus Fentanyl and Midazolam in Pediatric Patients Requiring Mechanical Ventilation and Sedation Therapy

Not Applicable
Completed
Conditions
Respiration Disorders
First Posted Date
1999-10-19
Last Posted Date
2015-03-25
Lead Sponsor
FDA Office of Orphan Products Development
Target Recruit Count
120
Registration Number
NCT00004424
© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy